142 related articles for article (PubMed ID: 38350242)
1. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
[TBL] [Abstract][Full Text] [Related]
3. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
[TBL] [Abstract][Full Text] [Related]
6. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.
Wang J; Liu Y; Zhang Y; Li X; Fang M; Qian D
Cancer Med; 2023 Jun; 12(11):12608-12621. PubMed ID: 37097161
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of cancer-associated fibroblast exosome-derived miR-29b-1-5p restrains vasculogenic mimicry and apoptosis while accelerating migration and invasion of gastric cancer cells via immunoglobulin domain-containing 1/zonula occluden-1 axis.
Wu C; Li D; Cheng X; Gu H; Qian Y; Feng L
Cell Cycle; 2023 Sep; 22(17):1807-1826. PubMed ID: 37587724
[No Abstract] [Full Text] [Related]
9. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma.
Zhang Z; Guo X; Guo X; Yu R; Qian M; Wang S; Gao X; Qiu W; Guo Q; Xu J; Chen Z; Wang H; Qi Y; Zhao R; Xue H; Li G
Aging (Albany NY); 2021 Feb; 13(4):5055-5068. PubMed ID: 33535172
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization.
Pan H; Yang L; Bai H; Luo J; Deng Y
J Ginseng Res; 2022 Sep; 46(5):636-645. PubMed ID: 36090681
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3.
Jiang M; Zhu Y; Yu H
Hum Exp Toxicol; 2021 Nov; 40(11):1974-1984. PubMed ID: 34002647
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p.
Wang L; Zhou S; Ruan Y; Wu X; Zhang X; Li Y; Ying D; Lu Y; Tian Y; Cheng G; Zhang J; Lv K; Zhou X
Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38526683
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression.
Chen K; Wang Q; Liu X; Wang F; Yang Y; Tian X
Int J Biol Sci; 2022; 18(3):1220-1237. PubMed ID: 35173549
[No Abstract] [Full Text] [Related]
17. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2.
Shang D; Xie C; Hu J; Tan J; Yuan Y; Liu Z; Yang Z
J Cell Mol Med; 2020 Jan; 24(1):588-604. PubMed ID: 31724333
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
[TBL] [Abstract][Full Text] [Related]
19. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
